Zusammenfassung
Störungen des Kalzium- und Phosphatstoffwechsels gehören nicht zu den typischen Komplikationen einer inadäquaten Hämodialyse, obwohl diese Behandlung durchaus in der Lage ist, vorhandene Knochenstoffwechselstörungen zu verschlechtern. Die Entwicklung der renalen Osteopathie beginnt in der Regel lange vor dem Hämodialysestadium, so daß davon ausgegangen werden muß, daß diejenigen Faktoren, die für die Pathogenese der renalen Osteopathie determinierend waren, auch während des Dialysestadiums die führende Rolle spielen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aarskog D, Aksnes L, Lehmann V (1980) Low 1,25-dihydroxy-vitamin D3 in heparin-induced osteopenia. Lancet 2: 650–651
Beehler CJ, Beckner JR, Rosenquist RC, Shankel SW (1980) Parathyroid hormone suppression by cimetidine in the uremic patient. Ann int Med 93: 840–841
Binswanger U, Schiffl H, Huggler M, Becker C (1980) 1,25-Dihydroxycholecalciferol treatment of uremic rats after high magnesium feeding. EDTA Abstracts 17: 10
Bouillon R, Verbeckmoes R, DeMoor P (1975) Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney Int 7: 422–432
Canterbury JM, Gauellas G, Bourgoignie JJ, Reiss E (1980) Metabolic consequences of oral administration of 24,25-dihydroxycholecalciverol to uremic dogs. J Clin Invest 65: 571–576
Caro JF, Castro JH, Glennon JA (1979) Effect of longerm propranolol administration parathyroid hormone and calcium concentration in primary hyperparathyroidism. Ann Int Med 91: 740–743
Coburn JW, Massry SG (1980) Uses and actions of 1,25-dihydroxyvitamin D3 in uremia. Contrib Nephrol 18
Drüeke T, Bordier PJ, Man NK, Jungers P, Marie -P (1977) Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry and parathyroid hormone in patients with renal osteodystrophy. Kidney Int 11: 267–274
Finco D, Olgaard K, Rothstein M, Schwartz J, Korkon A, Teitelbaum S, Klahr S, Slatopolsky E (1981) 24,25(OH)2D3 enhances bone formation in uremia in the abscence of an effect on PTH secretion. Kidney Int 19: 110
Fischer J (1981) Regulation der Biosynthese, der Sekretion and des Stoffwechsels von Parathormon. 5. Nephrologisches Seminar, Heidelberg 1981
Frame B, Sudhaker DR (1980) Calcium-regulating hormones Ann Int Med 93: 928–929
Hesch R-D, Henning HV, Gerlach W, Scheler F (1971) Früherkennung von Störungen der intestinalen Calciumabsorption bei Niereninsuffizienz. Klin Wochenschr 49: 115–120
Horst RL, Littledike ET, Gray RW, Napoli JL (1981) Impaired 24,25dihydroxyvitamin D production in anephric human and pig. J Clin Invest 67: 274–280
Jacob AI, Lambert PW, Canterbury JM, Gauellas G, Bourgoignie JJ (1980) Further studies with cimetidine in uremic dogs. (Abstr.) Am Soc Nephrol 13
Jacob AI, Lanier D, Canterbury J, Bourgoignie JJ (1980) Reduction by cimetidine of serum parathyroid hormone levels in uremic patients. N Eng J Med 302: 671–674
Kano K, Nonoda A, Yoneshima H, Suda T (1980) Serum concentrations of 25-hydroxyvitamin D in patients with various types of renal disease. Clin Nephrol 14: 274–279
Lilienfeld-Toal HV, Klehr HU (1980) Secondary hyperparathyroidism in early renal failure. Kidney Int 17: 411
Malluche HH, Ritz E, Lange HP, Kutschera J, Hodgson M, Seiffert U, Schoeppe W (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9: 355–362
Malluche HH, Ritz E, Lange HP, Schoeppe W (1976) Changes of bone histology during maintenance hemodialysis at various levels of dialysate calcium concentration. Clin Nephrol 6: 440–448
Malluche HH, Werner E, Ritz E (1978) Intestinal absorption of calcium in incipient and advanced renal failure. Miner Electrolyte Metab 1: 263–270
Massry SG (1979) Pathogenesis of secondary hyperparathyroidism in early renal failure: a multifactorial system including phosphate retention, skeletal resistance to PTH, and altered vitamin D metabolism. In: Norman AW, Schaefer K et al. (eds) Vitamin D: Basic research and its clinical application. W. de Gruyter, Berlin New York, pp 1203–1207
Massry SG, Goldstein DA, Malluche HH (1980) Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. Kidney Int 18: 409–418
Pieper R, v Herrath D, Hirsch F-W, Müller B, 0ffermann G, Rottka H, Schaefer K (In Vorbereitung) Failure to show a beneficial effect of oral calcium supplements in human periodontal disease.
Ritz E, Gebest J, Bummer J (1980) Beta-Rezeptorenblocker–eine Therapiemöglichkeit bei renalem sekundärem Hyperparathyreoidismus? Nieren Hochdruckkr 9: 176–180
Ritz E, Mehls O, Krempien B (1980) Calcium and phosphorus metabolism in maintenance hemodialysis. Adv Nephrol 9: 71–108
Schaefer K (1980) Die Behandlung der urämischen Osteopathie. Dtsch med Wochenschr 105: 1670–1671
Schaefer K, v Herrath D (1981) Aktueller Stand des Vitamin D-Stoffwechsels. Nieren Hochdruckkr 4: 142–147
Schaefer K, v Herrath D (1981) Vitamin D 1980–Eine Bestandsaufnahme. Klin Wochenschr 59: 525–534
Schaefer K, Schaefer P, Koeppe P, Opitz A, Höffler D (1968) Untersuchungen zur Frage der urämischen Osteopathie: Störungen der intestinalen Calcium-Resorption in Abhängigkeit von der Nierenfunktion. Dtsch Med Wochenschr 93: 1018–1022
Scribner BH (im Druck) Is bicarbonate dialysis really any better than acetate dialysis. Controv Nephrol
Slatopolsky E, Gray R, Adams ND et al. (1979) The pathogenesis of secondary hyperparathyroidism in early renal failure. In: Norman AW, Schaefer K et al. (eds) Vitamin D: Basic research and its clinical application. W. de Gruyter, Berlin New York, pp 1209–1215
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schaefer, K., von Herrath, D., Offermann, G. (1982). Renale Osteopathie: Pathogenese und Möglichkeiten der Therapie. In: Streicher, E., Schoeppe, W. (eds) Die adäquate Dialyse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81765-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-81765-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11243-3
Online ISBN: 978-3-642-81765-6
eBook Packages: Springer Book Archive